{
  "ticker": "AKRO",
  "success": true,
  "price": {
    "current": 54.65,
    "currency": "USD",
    "day_high": 54.825,
    "day_low": 54.42,
    "52_week_high": 58.4,
    "52_week_low": 21.34
  },
  "market_cap": {
    "value": 4499031040.0,
    "currency": "USD"
  },
  "shares_outstanding": 82324445.0,
  "volume": {
    "last": 11609142,
    "average_30d": 0
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -12.944102,
    "price_to_book": 4.5739875
  },
  "company_info": {
    "name": "Akero Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 1005577000.0,
    "total_liabilities": 47940000.0,
    "stockholders_equity": 957637000.0,
    "cash": 176032000.0,
    "marketable_securities": 561794000.0,
    "total_liquidity": 737826000.0,
    "total_debt": 1164000.0,
    "long_term_debt": 289000.0,
    "current_debt": 875000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": -67171000.0,
    "free_cash_flow": -67171000.0,
    "investing_cash_flow": 56781000.0,
    "financing_cash_flow": -34027000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 90236000.0,
    "research_and_development": 78883000.0,
    "interest_expense": 1092000.0,
    "net_income": -81566000.0,
    "revenue": 0.0,
    "gross_profit": null,
    "ebitda": -80474000.0,
    "error": null
  },
  "data_quality": {
    "flags": [
      "missing_volume",
      "volume_error:empty_history"
    ],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": false,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:47:24.097748",
    "url": "https://finance.yahoo.com/quote/AKRO",
    "data_hash": "841262b273bebb51"
  }
}